28 November 2017
Venue: Clare College, Cambridge
Scientific innovation and social change are driving us rapidly towards personalised healthcare. What will this future look like, and how will we get there?
Join an international line-up of expert speakers to explore how genomics and other emerging technologies are transforming the healthcare landscape, and consider some of the critical people, practical and policy issues that lie ahead. Our events always include high-quality discussion and plenty of networking opportunities.
This meeting is suitable for anyone with an interest in aspects of genomic medicine and personalised healthcare – practical, policy, or person-centred – including:
Tickets are £160 for the whole event including all refreshments, snacks, a networking lunch and closing wine reception, with an optional £8 fee for car parking.
Limited number of sponsorship packages available - view here.
Sir Jonathan Asbridge - President, European Society for Person-centred Healthcare / Clinical Director, Healthcare at Home
Dr Laura Blackburn - Policy Analyst (Biomedical Science), PHG Foundation
Prof Martyn Boutelle - Professor of Biomedical Sensors Engineering, Imperial College London
Prof Dame Sally Davies - Chief Medical Officer for England
Ms Carla Deakin - Associate Director, NICE Office for Market Access
Prof Andrew Flewitt - Professor of Electronic Engineering, Cambridge University
Dr Chiara Garratini - Intel Corporation's UK Health Innovation team
Dr Robert C. Green - Director, Genomes2People Research Program / Professor of Medicine (Genetics), Harvard Medical School
Prof Sue Hill - Chief Scientific Officer, NHS England
Dr Stephen Hilton - Senior Lecturer, University College London
Mr Claus F. Nielsen - Data for Good Foundation / Vice chair for Personal Connected Health Alliance Europe
Mr Francis White - VP Sales and Business Development, AliveCor Inc / NHS Innovation Fellow
|08:45||Registration and coffee|
|09:30||Welcome and overview||Dr Mark Kroese
Director, PHG Foundation
Creating a national genomic medicine service
|Prof Sue Hill
Chief Scientific Officer, NHS England
NHS England plans to improve patient outcomes through the introduction of personalised medicine, including better prediction and prevention of disease, more precise diagnosis, targeted interventions and a more participatory role for patients.
|Q & A|
|10:40||A vision of the future of diabetes care||Claus Nielsen
Co-producer, Data for Good Foundation
Vice Chair, Personal Connected Health Alliance Europe
Business Development Manager, Delta
Diabetes is a global health issue, with over 350 million people affected worldwide and numbers continuing to rise. How can personal connected health technologies support and empower diabetes patients to take control of their own health and wellbeing?
|Q & A|
Health technologies and the human factor
|Dr Chiara Garattini
Sir Jonathan Asbridge
President, European Society for Person-centred Healthcare
Clinical Director, Healthcare at Home
Chair: Alison Hall
Head of Humanities, PHG Foundation
Science and technology offer all kinds of new possibilities to personalise health and care, but how will humans interact with these technologies, and how can we ensure that they deliver benefits patients really want?
Innovations into practice in the NHS
NICE Office for Market Access
Chair: Dr Philippa Brice
External Affairs Director, PHG Foundation
Delivering the best scientific innovations to health professionals and patients in the NHS is an important policy priority; how does it play out in practice?
|14:00||Technologies to transform healthcare||Chair: Dr Sobia Raza
Head of Science, PHG Foundation
Dr Laura Blackburn
Policy Analyst (Biomedical Sciences), PHG Foundation
Prof Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London
Prof Andrew Flewitt
Professor of Electronic Engineering, Cambridge University
Dr Stephen Hilton
Senior Lecturer, University College London
The impact of modern genomics on medicine is substantial; explore how other technologies will transform healthcare, including digital health, ctDNA technologies and personalised 3D printing of drugs.
Empirical data on the Path to Genomic Medicine
|Dr Robert C. Green
Director, Genomes2People Program,
Harvard Medical School / Broad Institute
Genomics lies at the heart of future health, but what will a future of personalised medicine informed by genomics actually look like?
|Q & A|
|16:30||Genomics and health||Prof Dame Sally Davies
Chief Medical Officer for England
The CMO's recent Generation Genome report set out the many ways in which genomics can be expected to inform and improve medicine and public health now and in the future, and some of the policy steps that will be needed to realise this vision.
|17:00||Summary and close||Dr Mark Kroese
Director, PHG Foundation
Download programme here
Information on travelling by road, rail, coach and air is available here.
Unfortunately, parking is not available on site but there is secure parking available 10min away from the Gillespie Centre, Memorial Court, Clare College. The fee is £8 and can only be booked in advance on eventbrite. A map of the location of the car park and the Gillespie Centre is available here.
Alternative parking is available in the town centre at very high rates (up to £25 a day), or at several park&ride sites located on the outskirts of Cambridge. The park&ride stops in the centre of town and it is approximately a 15 minute walk from the centre to the Gillespie Centre.
If you have any queries please contact email@example.com.